Big Health’s SleepioRx Granted FDA Clearance   

Digital health technology developer Big Health said its SleepioRx digital treatment for insomnia was granted FDA clearance. SleepioRx is intended to treat chronic insomnia/insomnia disorder as an adjunct to usual care among adults.  

SleepioRx is based on Big Health’s existing Sleepio product, a prescription device. Sleepio offers;Cognitive Behavioral Therapy for Insomnia (CBT-I).;

SleepioRx is a 90-day prescription treatment. It can be obtained on the order of a licensed health care provider. It treats insomnia disorder by delivering evidence-based techniques targeting the cognitive and behavioral factors that maintain insomnia and chronic sleep problems . . .